Memory Loss

Current Research Studies

If you are a patient and would like to enroll in a clinical trial, click here.

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of MTAU9937A in Patients With Prodromal to Mild Alzheimer's Disease

PI:  Jennifer Arnold, MD

Study Contact:  Stephanie Kohlrus, BA CCRP         217.545.3013

Not enrolling

Open-Label Extension of Studies ATH-1017-AD-0201 and ATH-1017-AD-0202 in Subjects with Mild to Moderate Alzheimer's Disease

PI: Jennifer Arnold, MD

Study Contact: Sara Boarman             217.545.6829

Not enrolling

Caregiver Characteristics That May Predict When Patients With Alzheimer's Disease Are Placed in Long-term Care Facilities

PI:  Tom Ala, MD

Study Contact:  Stephanie Kohlrus, BA, CCRP          217.545.3013

ENROLLING

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease, Phase III

PI: Jennifer Arnold, MD

Study Contact: Sara Boarman        217.545.6829

Not enrolling

A Randomized, Double-Blind, Placeo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer's Disease

PI: Jennifer Arnold, MD

Study Contact: Sara Boarman        217.545.6829

ENROLLING